glp-1 trump Medicare to Cover Drugs for as Little as $50 a Month Under Plan Eli Lilly and Novo Nordisk
Description
IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation
The nearly 14% of the women who had taken a GLP-1 medication were 30.5% less likely to develop breast cancer than those who had never taken one of these drugs
Summary Mendelian randomization (SMR) analysis of GLP1R and mood disorders When cis-eQTLs were used as IVs, there may be an inclusion of too many inappropriate IVs, in which case the IVW weighting method may lead to false-positive results

Neurology 102 , 3350 (2024)